IL95849A - An anticoagulant preparation containing acetylsalicylic acid and a history of carbacicline - Google Patents

An anticoagulant preparation containing acetylsalicylic acid and a history of carbacicline

Info

Publication number
IL95849A
IL95849A IL9584990A IL9584990A IL95849A IL 95849 A IL95849 A IL 95849A IL 9584990 A IL9584990 A IL 9584990A IL 9584990 A IL9584990 A IL 9584990A IL 95849 A IL95849 A IL 95849A
Authority
IL
Israel
Prior art keywords
cicaprost
composition according
carbacyclin
asa
acetylsalicylic acid
Prior art date
Application number
IL9584990A
Other languages
English (en)
Hebrew (he)
Other versions
IL95849A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL95849A0 publication Critical patent/IL95849A0/xx
Publication of IL95849A publication Critical patent/IL95849A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL9584990A 1989-09-29 1990-09-28 An anticoagulant preparation containing acetylsalicylic acid and a history of carbacicline IL95849A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3933027A DE3933027A1 (de) 1989-09-29 1989-09-29 Kombinationspraeparat mit antithrombotischer wirkung

Publications (2)

Publication Number Publication Date
IL95849A0 IL95849A0 (en) 1991-06-30
IL95849A true IL95849A (en) 1995-03-30

Family

ID=6390758

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9584990A IL95849A (en) 1989-09-29 1990-09-28 An anticoagulant preparation containing acetylsalicylic acid and a history of carbacicline

Country Status (19)

Country Link
US (1) US5093325A (fr)
EP (1) EP0420368B1 (fr)
JP (1) JP3040463B2 (fr)
AT (1) ATE92325T1 (fr)
CA (1) CA2069296C (fr)
CS (1) CS277650B6 (fr)
DD (1) DD299153A5 (fr)
DE (2) DE3933027A1 (fr)
DK (1) DK0420368T3 (fr)
ES (1) ES2058771T3 (fr)
HU (1) HUT60140A (fr)
IE (1) IE903503A1 (fr)
IL (1) IL95849A (fr)
NO (1) NO921223D0 (fr)
NZ (1) NZ235521A (fr)
PT (1) PT95456B (fr)
RU (1) RU2097039C1 (fr)
WO (1) WO1991004740A1 (fr)
ZA (1) ZA907808B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040180865A1 (en) * 1993-06-04 2004-09-16 Jeffry W. Kreamer Aspirin and vitamin and/or trace element compositions for the amelioration and treatment of vascular disease
US5830837A (en) * 1994-11-22 1998-11-03 Novo Nordisk A/S Amylase variants
US5709541A (en) * 1995-06-26 1998-01-20 Selas Corporation Of America Method and apparatus for reducing NOx emissions in a gas burner
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
EP1596858A1 (fr) * 2003-02-14 2005-11-23 Medical Research Council Antagonistes du récepteur ip utilises dans le traitement des pathologies de l'utérus
ES2375064T3 (es) * 2004-05-17 2012-02-24 Medtronic, Inc. Sistema de determinación de heparina en el lugar de atención al paciente.
JP2009529057A (ja) * 2006-03-08 2009-08-13 コートリア・コーポレーシヨン Cox−関連胃損傷を予防するための非−選択的cox阻害剤との組み合わせ療法
WO2011134478A2 (fr) * 2010-04-29 2011-11-03 Thrombologic Aps Méthodes de traitement de patients présentant un risque accru de développer des événements ischémiques et composés associés
US9345678B2 (en) * 2013-03-13 2016-05-24 Allergan, Inc. Prostanoid receptor agonist compounds and methods of use for same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524051A1 (de) * 1985-07-05 1987-01-15 Hoechst Ag Kombinationspraeparate aus hemmstoffen der thrombozytenaggregation und deren verwendung

Also Published As

Publication number Publication date
AU6419090A (en) 1991-04-28
CS277650B6 (en) 1993-03-17
WO1991004740A1 (fr) 1991-04-18
ATE92325T1 (de) 1993-08-15
JP3040463B2 (ja) 2000-05-15
DK0420368T3 (da) 1993-11-15
CA2069296C (fr) 2002-04-23
NO921223L (no) 1992-03-27
IL95849A0 (en) 1991-06-30
ZA907808B (en) 1992-01-29
AU640692B2 (en) 1993-09-02
US5093325A (en) 1992-03-03
CS472690A3 (en) 1992-08-12
PT95456B (pt) 1997-07-31
NZ235521A (en) 1993-03-26
NO921223D0 (no) 1992-03-27
IE903503A1 (en) 1991-04-10
HU9201045D0 (en) 1992-06-29
RU2097039C1 (ru) 1997-11-27
PT95456A (pt) 1991-08-14
DE59002185D1 (de) 1993-09-09
DE3933027A1 (de) 1991-04-11
HUT60140A (en) 1992-08-28
JPH05500805A (ja) 1993-02-18
CA2069296A1 (fr) 1991-03-30
EP0420368A1 (fr) 1991-04-03
ES2058771T3 (es) 1994-11-01
EP0420368B1 (fr) 1993-08-04
DD299153A5 (de) 1992-04-02

Similar Documents

Publication Publication Date Title
CN1116042C (zh) 含有氯吡格雷和一种抗血栓形成药活性成分的组合物
Chong et al. Heparin‐induced thrombocytopenia: effect of heparin platelet antibody on platelets
US5093325A (en) Combination preparation having antithrombotic action
JPH04504710A (ja) 抗血栓組成物
Küster et al. Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man
Louie et al. Diadenosine 5′, 5‴-P1, P4-tetraphosphate, a potential antithrombotic agent
CN103908460B (zh) 三七皂苷Fc的医药用途
Silver et al. Blood platelets and the inflammatory process
Tohgi et al. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
JPS6257605B2 (fr)
US4097602A (en) Method of inhibiting blood platelet aggregation
AU660449B2 (en) Prostacycline and carbacycline derivatives as agents for treating feverish complaints
Hall et al. The reduction of platelet thrombi on damaged vessel wall by a thromboxane synthetase inhibitor in rabbits
Ito et al. Role of activated platelets in endotoxin-induced DIC in rats
US4705792A (en) 4-amino-2-(imidazolidin-2-on-1-yl)-5-(3-trifluoromethyl-phenyllaminocarbonyl)pyrimidines for antithrombotic prophylaxis and treatment
JPH10101556A (ja) ファクターd阻害剤
Nagatsuka et al. A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin.
IE59338B1 (en) Prostacyclins, their analogues or prostaglandins and thromboxane antagonists for the treatment of thrombotic and thrombo-embolic syndromes
AU2002363023B2 (en) A combination product comprising melagatran and dexamethasone
JP3169343B2 (ja) アスピリンおよび抗−Xaオリゴ糖の組合せを含有する組成物ならびにアスピリンと任意的に組み合わせた抗−Xaオリゴ糖の使用
JP2006016301A (ja) アンヒドロフルクトースおよびその誘導体の血小板凝集抑制剤
KR100231978B1 (ko) 아스피린 회합체 및 안티-Xa 올리고사카라이드를 함유하는 조성물과 아스피린 결합물내 안티-XA 올리고사카라이드의 용도
Matsuda et al. Prophylactic administrations of aspirin for the prevention of thrombo-embolic complications in postoperative reactive thrombocytosis
Demke et al. The effect of itazigrel and aspirin on the mucosa of the esophagus, stomach, and duodenum of normal subjects
Nossel et al. B. Anticoagulants

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees